Activity of anthracyclines in refractory ovarian cancer: recent experience and review

Cancer Invest. 1997;15(4):329-34. doi: 10.3109/07357909709039736.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Aged
  • Antibiotics, Antineoplastic / therapeutic use*
  • Doxorubicin / therapeutic use*
  • Female
  • Humans
  • Liposomes
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antibiotics, Antineoplastic
  • Liposomes
  • Doxorubicin